## CAH: Cardinal Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 2.1% below STRENGTH zone (4.0-10.0%); PEG 1.97 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (37% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($201.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Vontobel Holding Ltd. Sells 33,101 Shares of Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251228T133622 | Bullish | Relevance: 100%
- Vontobel Holding Ltd. significantly reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 83.9% in Q3, selling 33,101 shares and retaining 6,370 shares valued at approximately $1.0 million. Despite this sale, Wall Street analysts maintain a generally positive outlook with an average target price of $209.00 and numerous "buy" ratings. Cardinal Health also reported strong Q3 earnings, beating estimates with $2.55 EPS and generating $64.01 billion in revenue, and announced a quarterly dividend of $0.5107.

**2. Why You Might Be Interested In Cardinal Health, Inc. (NYSE:CAH) For Its Upcoming Dividend**
- Source: 富途牛牛 | 20251228T120808 | Bullish | Relevance: 100%
- Cardinal Health, Inc. (NYSE:CAH) is set to trade ex-dividend shortly, with a payment of US$0.5107 per share expected on January 15th. The company exhibits a conservative payout ratio of 31% of profit and 11% of free cash flow, suggesting a sustainable dividend. With rapid earnings per share growth of 23% annually over the last five years, Cardinal Health presents an appealing option for dividend investors.

**3. Here's What We Like About Cardinal Health's (NYSE:CAH) Upcoming Dividend**
- Source: Simply Wall Street | 20251228T120758 | Bullish | Relevance: 100%
- Cardinal Health (NYSE:CAH) is expected to go ex-dividend soon, with a conservative payout ratio of 31% of profit and 11% of free cash flow. The company has growing earnings per share, up 23% annually for the past five years, and has consistently increased its dividend over the last decade. This combination of strong earnings growth and a low payout ratio suggests a sustainable and potentially increasing dividend for investors.

**4. Columbus Macro LLC Has $5.73 Million Position in Cardinal Health, Inc. $CAH**
- Source: MarketBeat | 20251228T093704 | Bullish | Relevance: 100%
- Columbus Macro LLC significantly increased its stake in Cardinal Health, Inc. (NYSE:CAH), owning 36,529 shares valued at $5.73 million. Cardinal Health surpassed Q3 financial expectations and received positive analyst sentiment, with several firms raising their price targets and a consensus "Moderate Buy" rating. The company announced a quarterly dividend of $0.5107 per share, yielding 1.0% annually.

**5. Are Investors Undervaluing Cardinal Health (CAH) Right Now?**
- Source: Yahoo Finance | 20251226T140751 | Bullish | Relevance: 100%
- Cardinal Health (CAH) currently holds a Zacks Rank #2 (Buy) and a Value Grade of A, indicating it may be undervalued. The stock exhibits favorable P/E, PEG, and P/CF ratios compared to its industry, suggesting it's a strong value stock. These metrics, combined with a positive earnings outlook, point to CAH as a potentially attractive investment.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $243 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($0.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 13.2% (+3.0%)
- Vanguard Group Inc: 13.0% (+0.8%)
- State Street Corpora: 5.2% (-3.0%)
- Geode Capital Manage: 2.7% (+1.5%)
- Wellington Managemen: 2.4% (+153.2%)

### Key Risks

1. Volume divergence: price rising (+2.5% MRS) on declining volume (37% of avg) suggests distribution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.97 elevated, pricing in significant growth expectations. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $49.5B |
| Beta | 0.64 |
| 52W Range | $117.53 - $214.93 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.97 |
| Forward P/E | 18.8 |
| Current P/E | 21.2 |
| YoY Growth | 12.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.4% to 2.1% (+2.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.9pp (needs >4.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 3.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 37% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.12% (CS: 78) | Neutral |
| RSI_14 | 69.1 | Neutral |
| MACD Histogram | 0.19 | Bullish |
| vs SMA20 | 1.031x | Above |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.292x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $208.27
- **Stop Loss:** $201.59 (3.2% risk)
- **Target:** $214.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 197
- **Position Value:** $41,029.19
- **Portfolio %:** 41.03%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-29 (Est: $2.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.17 | $2.55 | +17.3% |
| 2025Q2 | $2.03 | $2.08 | +2.4% |
| 2025Q1 | $2.15 | $2.35 | +9.4% |
| 2024Q4 | $1.76 | $1.93 | +9.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*